Corynebacterium macginleyi conjunctivitis in Canada.
This report describes for the first time Corynebacterium macginleyi as a cause of conjunctivitis in Canada, where menaquinone analysis was done as part of the strain characterization. This species is typically isolated from ocular surfaces of patients from Europe and Japan. The isolate was resistant to erythromycin and clindamycin.
Alsuwaidi
Ahmed R
AR
United Arab Emirates University, Department of Paediatrics, Al Ain, United Arab Emirates.
Wiebe
Deborah
D
Burdz
Tamara
T
Ng
Betty
B
Reimer
Aleisha
A
Singh
Cathleen
C
Bernard
Kathryn
K
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D015373:Bacterial Typing Techniques; D002170:Canada; D002981:Clindamycin / Q000494:pharmacology; D016000:Cluster Analysis; D003231:Conjunctivitis / Q000382:microbiology* / Q000473:pathology; D003352:Corynebacterium / Q000145:classification / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification*; D003354:Corynebacterium Infections / Q000175:diagnosis* / Q000382:microbiology / Q000473:pathology; D004269:DNA, Bacterial / Q000737:chemistry / Q000235:genetics; D004275:DNA, Ribosomal / Q000737:chemistry / Q000235:genetics; D024881:Drug Resistance, Bacterial; D004917:Erythromycin / Q000494:pharmacology; D005260:Female; D006801:Humans; D008875:Middle Aged; D008969:Molecular Sequence Data; D010802:Phylogeny; D012336:RNA, Ribosomal, 16S / Q000235:genetics; D017422:Sequence Analysis, DNA; D024482:Vitamin K 2 / Q000032:analysis
D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D004275:DNA, Ribosomal; D012336:RNA, Ribosomal, 16S; D024482:Vitamin K 2; D002981:Clindamycin; D004917:Erythromycin